Langermann Sol
SEC insider (Form 3/4/5 filer). CIK 0001775459. Chief Scientific Officer at NextCure, Inc. (NXTC). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 31, 2025. Located in BELTSVILLE, MD.
Companies Langermann Sol has filed insider reports for
- NextCure, Inc. (NXTC): Officer, Chief Scientific Officer
Langermann Sol
CIK: 0001775459
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NXTC
NextCure, Inc.
Officer